Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link
about
Interaction of occupational and personal risk factors in workforce health and safetyLiver tumors in children with metabolic disordersHepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trendsNutrition and metabolism in hepatocellular carcinomaRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaSurveillance for hepatocellular carcinoma.Hepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseObesity-Related Digestive Diseases and Their PathophysiologyZebrafish as a disease model for studying human hepatocellular carcinomaOral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- miceDifference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in miceAggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in ratsAMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosisNon-alcoholic fatty liver disease: An expanded reviewMaternal obesity programmes offspring development of non-alcoholic fatty pancreas diseasePitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss.Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patientsSerum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome in Korean adult men.Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.DEC1 nuclear expression: a marker of differentiation grade in hepatocellular carcinomaThe clinical significance of serum ferritin in pediatric non-alcoholic Fatty liver diseaseActivation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis.Physical Activity is Related to Fatty Liver Marker in Obese Youth, Independently of Central Obesity or Cardiorespiratory Fitness.Apelin and insulin resistance: another arrow for the quiver?New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in JapanPotential epigenetic mechanism in non-alcoholic Fatty liver diseaseHCC, diet and metabolic factors: Diet and HCCHeat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome.
P2860
Q23919248-73339FDB-580C-4FE1-B073-59570CAE7DA6Q26770292-B2B75EBC-D527-40AB-8AEC-56555F82775FQ26783881-BE6FA2C0-8A66-4284-82CA-210185A858CCQ26824893-C9A07C11-5B5F-47FE-B344-AED65F8EEBC0Q26830194-ADE7FCA5-E836-4EF5-ABD4-4AD79DD80693Q26862862-802232C6-8584-42F1-BCBA-D4103DB923B9Q27023524-DAB84A9B-AD24-4521-8009-E269461DCCC8Q27690269-13337590-AA72-4C4B-AA9D-13C4DD12180CQ28066100-22D0085B-4731-49AC-9F52-1EFD45B49D1CQ28073381-98F28D3D-3D9E-40F0-A50F-8E66D0403570Q28081542-EE8561CC-7BFF-49D2-9F84-A4E16C497718Q28476642-D21F9A21-056D-47B6-AEEE-4408DC3362BFQ28507402-D565E0EB-7AF8-484A-AC9D-3DD1CF291EBEQ28573665-F0195CBE-9D65-4CD0-A21A-80B92AEADE78Q31158130-F813A100-127D-4C9D-AF72-C1A5B5C40209Q33397694-7CD05DC6-FC3A-484A-8A68-13771A4255DBQ33638516-3C96F902-8C60-4021-970D-6B646FAF0EB5Q33789868-9BD9704C-8665-47FC-B67F-B976B039E219Q33882340-4675B4AB-FA1D-4ACA-A17E-72651B2DEE1BQ33944911-A176C22F-E64A-4A84-9179-F920F2159810Q34077811-2BF39A2C-C0FC-4B0E-8193-78BEED2D9AEAQ34131801-293E7980-2C50-4B93-8E16-040EF3AC97DEQ34185231-50DFF3CA-7860-470F-9DF2-D9F9A6B81EF3Q34255487-43AF5CFD-67C3-49FF-B764-EDE47B53CDEFQ34422414-88A29992-E7FB-4462-AB2F-5C9729EEBCF8Q34635693-9B48B342-F61B-4C52-845D-7785BF136624Q34692038-670FF907-7392-46CF-82AE-084DB6B3257AQ34765518-26DB3372-35F0-461A-80A5-9365CECE7CDBQ34766122-0E06DFD5-D95C-49BE-B6C7-5B17112A5841Q34796362-B95ABB93-78B5-40A8-BC79-5ADA87366CE4Q34821020-8FDC728F-4E94-495C-9981-B08F5350E92CQ34863421-7A04D9C5-FB4C-4898-A1D9-DF16B8E17B10Q34923599-5B07798E-DCF0-4A0E-B79F-16154F88CEE7Q34992761-13B45E31-69A3-4A45-8778-14E37ADD6B40Q35014575-8DCCFB15-B586-43FD-8141-87A0A2B35479Q35166911-B08E0E39-C08B-4C62-89DF-C3FF8400E218Q35289022-A2467225-353E-4B20-A927-D84990DA5548Q35380845-2F082B0E-CF42-4FC2-85D4-984D59E935BEQ35507651-7A3776D1-6121-4DE0-9B68-23D75AF950D1Q35545513-74D4B215-7F9F-4ABB-B675-231A62946E09
P2860
Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@ast
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@en
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@nl
type
label
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@ast
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@en
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@nl
prefLabel
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@ast
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@en
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@nl
P2860
P3181
P356
P1433
P1476
Metabolic syndrome and hepatoc ...... pidemics with a potential link
@en
P2093
Abby B Siegel
Andrew X Zhu
P2860
P304
P3181
P356
10.1002/CNCR.24687
P407
P577
2009-12-15T00:00:00Z